Business

IPO Listing: Superb listing of Supriya Lifescience, shares opened with a rise of 55 percent from the issue price

Written by admin

IPO Listing: Superb listing of Supriya Lifescience, shares opened with a rise of 55 percent from the issue price

The company’s focus is also on R&D. The market capitalization of Supriya License reached Rs 3,420 crore during the opening.

There has been a great listing of the shares of Supriya Lifescience today. Shares of this Pharma API Manufacturers were seen trading at Rs 425 with a jump of 55.11 percent. The issue price on the upper band was Rs 274 per share. That is, it has opened by increasing by Rs 151 from its issue price.

Market capitalization reaches Rs 3,420 crore

In addition to the issue of fresh shares in the Rs 700 crore IPO of Supriya Lifesciences, there was also an offer for sale (OFS). This company is a manufacturer and supplier of APIs. The company’s focus is also on R&D. The market capitalization of Supriya License reached Rs 3,420 crore during the opening. The Rs 700-crore IPO of Supriya Lifesciences opened on December 16 and investors had a chance to invest till December 20.
Under the IPO, new shares worth Rs 200 crore were issued while promoter Satish Waman Bagh sold shares worth Rs 500 crore under the Offer for Sale (OFS). Earlier, the promoter’s stake in the company was 99.26 per cent, while the promoter group held 0.72 per cent in it. 75 per cent of the issue was reserved for Qualified Institutional Buyers (QIBs), 15 per cent for non-institutional investors and 10 per cent for retail investors. He was the Book Running Lead Manager of ICICI Securities and Axis Capital Issues.

Upcoming IPO: IPO of these two companies got SEBI approval, will these new shares make investors rich?

What does the company do?

The main focus of Supriya Lifesciences, a company that manufactures and supplies APIs, is on Research and Development (R&D). According to the data available till 31 October 2021, the company manufactures 38 APIs. From 1 April 2021 to 31 October 2021, the company’s products were exported to 1296 customers including 346 distributors in 86 countries. The company’s API business is spread across Europe, Latin America, Asia and North America.
Talking about the financials of the company, the net profit (Profit After Tax) of the company has increased continuously. The company had a net profit of Rs 39.42 crore in the financial year 2019, which increased to Rs 73.37 crore in the next year. Talking about the last financial year, the company had a net profit of Rs 123.83 crore. In the first half of the current financial year, April-September 2021, the company made a net profit of Rs 65.96 crore.

Financial Express Telegram Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

#IPO #Listing #Superb #listing #Supriya #Lifescience #shares #opened #rise #percent #issue #price

About the author

admin

Leave a Comment